The activity of beta-adrenoceptor blocking agents in protecting mice from the cardiotoxic effects of ouabain.
D000083:Acetanilides / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D003975:Diazepam / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D004983:Ethanolamines / Q000494:pharmacology; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009578:Nitrobenzenes / Q000494:pharmacology; D010042:Ouabain / Q000037:antagonists & inhibitors* / Q000633:toxicity; D010627:Phenethylamines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D013015:Sotalol / Q000494:pharmacology
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000889:Anti-Arrhythmia Agents; D004983:Ethanolamines; D009578:Nitrobenzenes; D010627:Phenethylamines; D011437:Propylamines; D010042:Ouabain; D008012:Lidocaine; D011433:Propranolol; D013015:Sotalol; D011802:Quinidine; D003975:Diazepam